How do I buy Viking Therapeutics (VKTX) stock?

You can purchase shares of Viking Therapeutics (NASDAQ:VKTX) through any online brokerage.View our list of the best stock brokerages

Who are Viking Therapeutics (VKTX) competitors?

Other companies in Viking Therapeutics’s space includes: IDEAYA Biosciences Inc (NASDAQ:IDYA), Legend Biotech Corp (NASDAQ:LEGN), Centessa Pharmaceuticals PLC (NASDAQ:CNTA), Arcutis Biotherapeutics Inc (NASDAQ:ARQT) and Xenon Pharmaceuticals Inc (NASDAQ:XENE).

What is the forecast, or price target, for Viking Therapeutics (VKTX) stock?

Viking Therapeutics has a consensus price target of $80.55.

What is the current price for Viking Therapeutics (VKTX)?

The stock price for Viking Therapeutics (NASDAQ: VKTX) is $31.57 last updated January 27, 2026 at 7:59 PM EST.

Does Viking Therapeutics (VKTX) pay a dividend?

There are no upcoming dividends for Viking Therapeutics.

When is Viking Therapeutics (NASDAQ:VKTX) reporting earnings?

Viking Therapeutics does not have any upcoming earnings scheduled.

Is Viking Therapeutics (VKTX) going to split?

There is no upcoming split for Viking Therapeutics.

What sector and industry does Viking Therapeutics (VKTX) operate in?

Viking Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Viking Therapeutics (VKTX) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 pr...

Comments